venetoclax
Venetoclax is a medication used primarily to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by targeting a protein called BCL-2, which helps cancer cells survive. By blocking this protein, Venetoclax encourages cancer cells to die, allowing healthier cells to grow and function properly. This targeted approach can lead to effective treatment with potentially fewer side effects compared to traditional chemotherapy. It's often used as part of a broader treatment plan, sometimes in combination with other therapies, to improve patient outcomes.
Additional Insights
-
Venetoclax is a medication used to treat certain types of blood cancers, especially chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting a protein called BCL-2, which helps cancer cells survive. By blocking this protein, venetoclax promotes cancer cell death and can help reduce the number of cancer cells in the body. It is often used in combination with other treatments and is taken in pill form. Its ability to specifically target cancer cells makes it a valuable option in cancer therapy.